Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy
NCT ID: NCT05187026
Last Updated: 2022-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2016-12-09
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma
NCT02264379
Prostate Cancer Stereotactic Radiotherapy
NCT02319239
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
NCT07245745
Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer
NCT00520546
Hypofractionated Radiosurgery for Localised Prostate Cancer
NCT02635256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EPIC-26 follow-up
All men will receive EPIC-26 in paper and also an electronic version.
electronic PROMs questionnaire
Patients are asked to complete EPIC-26 questionnaire in paper and electronically
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electronic PROMs questionnaire
Patients are asked to complete EPIC-26 questionnaire in paper and electronically
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to complete EPIC-26 questionnaires both in paper and electronically
* willing to consent for the study
Exclusion Criteria
18 Years
100 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antti Rannikko
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antti S Rannikko, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Helsinki University Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital
Helsinki, Uusimaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
study group website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2067/2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.